Report Overview: The Global Sickle Cell Disease Diagnosis Market achieved a valuation of $1.7 Billion in 2022 and is anticipated to exceed $4.31 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 12.4% during the forecast period from 2024 to 2032. Key Market Players: Alpha Labs, Atlas Medical, BioMedomics Inc, Mayo Clinic, Fisher Scientific, Cigna, ASI, Silver...